Infection after ERCP, and antibiotic prophylaxis: a sequential quality-improvement approach over 11 years

Gastrointest Endosc. 2008 Mar;67(3):471-5. doi: 10.1016/j.gie.2007.06.065. Epub 2007 Dec 3.

Abstract

Background: Infection is a known complication of ERCP procedures, and the role of antibiotic prophylaxis is uncertain.

Objective: To document the incidence of infection after ERCP while changing the policy for antibiotic prophylaxis.

Design: Retrospective analysis of data collected prospectively on infection complications, with progressive reduction in the use of prophylactic antibiotics.

Setting: Single-center university referral hospital.

Patients: A total of 11,484 ERCP procedures were documented prospectively over a period of 11 years.

Interventions: After baseline assessment, the use of prophylactic antibiotics was sequentially reduced and simplified in 3 phases.

Main outcome measurements: Incidence of infection, categorized by severity.

Results: The infection rate was low overall and decreased significantly with time, from 0.48% to 0.25%, despite a marked reduction in the proportion of patients given antibiotics (from 95% to 25%). Multivariate analysis also showed that the only category of patients at increased risk for infection (despite antibiotics) was the subgroup undergoing interventions for biliary problems after liver transplantation.

Limitations: A lack of routine follow-up may mean that some delayed infectious complications were not recorded. The low risk of infection in this series may reflect the high technical success rate for relief of biliary obstruction; thus, our current minimalist antibiotic policy may not be generalizable to community practice.

Conclusions: Infectious complications of ERCP can be kept to a minimum with a limited use of prophylactic antibiotics.

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Antibiotic Prophylaxis / methods*
  • Biliary Tract Diseases / surgery*
  • Cholangiopancreatography, Endoscopic Retrograde / adverse effects*
  • Cohort Studies
  • Female
  • Humans
  • Incidence
  • Male
  • Patient Selection
  • Retrospective Studies
  • Risk Factors
  • Surgical Wound Infection / epidemiology*
  • Surgical Wound Infection / prevention & control
  • Time Factors
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents